# Remifentanil Hydrochloride Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 9
- Latest FDA row update: 08/20/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Fresenius Kabi USA, LLC — Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) — FDA availability: Available — updated: 08/04/2026
- Fresenius Kabi USA, LLC — Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) — FDA availability: Unavailable — updated: 08/04/2026
- Fresenius Kabi USA, LLC — Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) — FDA availability: Available — updated: 08/04/2026
- Hikma Pharmaceuticals USA, Inc. — Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) — FDA availability: Unavailable — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) — FDA availability: Unavailable — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) — FDA availability: Available — updated: 08/13/2026
- Mylan Institutional, a Viatris Company — Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) — FDA availability: Available — updated: 08/20/2026
- Mylan Institutional, a Viatris Company — Ultiva, Injection, 2 mg (NDC 72078-035-02) — FDA availability: Available — updated: 08/20/2026
- Mylan Institutional, a Viatris Company — Ultiva, Injection, 5 mg (NDC 72078-036-05) — FDA availability: Available — updated: 08/20/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/remifentanil-hydrochloride-injection)
- [JSON record](https://citefacts.com/shortages/remifentanil-hydrochloride-injection.json)